PRME Dividend History & Analysis | N/A Yield
PRME has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,406 M | 13.7% | 7.37% |
| ABBV | 406,304 M | 3.63% | 9.56% |
| AMGN | 179,831 M | 3.68% | 6.22% |
| GILD | 155,932 M | 2.57% | 6.37% |
| HLN | 45,108 M | 1.75% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,406 M | 134% | 91.7% |
| HLN | 45,108 M | 51.0% | 100% |
| AMGN | 179,831 M | 7.84% | 100% |
| ABBV | 406,304 M | 5.98% | 100% |
| GILD | 155,932 M | 2.74% | 100% |
Similar Stocks with Attractive Dividends - Compare PRME Dividends with its Peer-Group
3.63% Yield
3.68% Yield
2.57% Yield
1.75% Yield
PRME Dividend History: as of January 2026
No dividends paid yet.PRME Dividend FAQ
Prime Medicine, Inc. (NASDAQ: PRME) is a Cambridge-based biotech that commercializes its proprietary “Prime Editing” platform-a CRISPR-derived, single-turnover gene-editing system that inserts precise DNA changes without inducing double-stranded breaks. The technology combines a catalytically-improved Cas9 nickase, a reverse-transcriptase (RT) domain, and a pegRNA that both locates the target site and encodes the desired edit. Prime Medicine’s current focus is on partnership-driven programs, most notably a research collaboration with Cimeio Therapeutics to create “Prime-Edited Shielded-Cell & Immunotherapy” pairs for genetic diseases, acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS). The company was incorporated in 2019 and trades as a common stock in the U.S. biotechnology sub-industry.
What is the Dividend Yield of PRME?
As of January 2026, PRME`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 3.47.Does PRME pay a dividend?
As of January 2026 PRME does not pay a dividend.How often does PRME pay dividends?
Over the last 12 months, PRME has issued dividend payments.PRME dividend forecast
Based on historical data, the forecasted dividends per share for PRME for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will PRME pay dividends in 2026?
The next Ex-Dividend date for Prime Medicine, Common (PRME) is currently unknown.What is the next Ex-Dividend Date for PRME?
The next Ex-Dividend date for Prime Medicine, Common (PRME) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of PRME?
PRME's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of PRME?
PRME's 5-Year Yield on Cost is -%. If you bought PRME's shares at 15.37 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of PRME?
PRME Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does PRME have a good Dividend Yield?
PRME`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of PRME?
The Dividend Payout Ratio of PRME is unknown.What is the Dividend Rating of PRME?
PRME`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-12-15 02:18